Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 107: 1591-1599, 2009. First published September 10, 2009; doi:10.1152/japplphysiol.90548.2008
8750-7587/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
107/5/1591    most recent
90548.2008v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Krause, K. L.
Right arrow Articles by Forster, H. V.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krause, K. L.
Right arrow Articles by Forster, H. V.

µ-Opioid receptor agonist injections into the presumed pre-Bötzinger complex and the surrounding region of awake goats do not alter eupneic breathing

K. L. Krause,1 S. E. Neumueller,1 B. D. Marshall,1 T. Kiner,1 J. M. Bonis,1 L. G. Pan,3 B. Qian,1 and H. V. Forster1,2

1Department of Physiology, Medical College of Wisconsin, ; 2Department of Veterans Affairs Medical Center, and ; 3Department of Physical Therapy, Marquette University, Milwaukee, Wisconsin

Submitted 21 April 2008 ; accepted in final form 17 August 2009

Opioids are clinically important in the alleviation of pain. An undesirable side effect of opioids is depression of breathing. Data from isolated preparations suggest this effect is due to attenuation of discharge activity of neurons in the pre-Bötzinger complex (preBötzC), a medullary area with respiratory rhythmogenic properties. The purpose of this study was to examine how [D-Ala(2),N-Me-Phe(4),Gly(5)-ol]-enkephalin (DAMGO), a µ-opioid receptor agonist, affected breathing after injection into the presumed preBötzC of the adult awake goat. We hypothesized that DAMGO would cause breathing to decrease and become irregular when injected into the presumed preBötzC and the surrounding region of the conscious animal. We further hypothesized that ventilatory sensitivity to CO2 and hypoxia would be blunted after the injection of DAMGO. Microtubules were bilaterally implanted into the presumed preBötzC of 10 adult female goats. After recovery from the surgery, DAMGO (0.5–10 µl, 1 nM–10 µM) was injected into the presumed preBötzC during the awake state. DAMGO had no effect on pulmonary ventilation [inspiratory minute ventilation (VI)], respiratory rhythm and pattern, the activation pattern of inspiratory and expiratory muscles, or arterial blood gases during eupneic breathing conditions (P > 0.10). However, DAMGO attenuated (P < 0.05) the evoked increase in breathing frequency when inspired CO2 was increased, and DAMGO attenuated the VI response to reduction of inspired O2 to 10.8% (P < 0.05). We conclude that our data do not provide support for the concept that in awake mammals opioid depression of breathing is due to a directed action of opioids on preBötzC neurons.

chemosensitivity; [D-Ala(2),N-Me-Phe(4),Gly(5)-ol]-enkephalin



Address for reprint requests and other correspondence: K. L. Krause, 8701 Watertown Plank Rd., Milwaukee, WI 53226 (e-mail: klkrause{at}mcw.edu).







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.